WARTEC 5 MG
PODOPHYLLOTOXIN : 5 MG · DIN 02074788 · STIEFEL LABORATORIES (IRELAND) LIMITED
Health Canada status: CANCELLED POST MARKET
What is WARTEC?
WARTEC 5 MG contains PODOPHYLLOTOXIN : 5 MG. It is listed in the Health Canada Drug Product Database under DIN 02074788, held by STIEFEL LABORATORIES (IRELAND) LIMITED, supplied as LIQUID for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 30-Apr-2015. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is WARTEC used for?
WARTEC ® (Podofilox 0.5% topical solution) is indicated for the topical treatment of external genital warts (Condylomata acuminata) confined to the penile and vulvar regions.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02074788 |
|---|---|
| Brand name | WARTEC |
| Generic / active ingredient | PODOPHYLLOTOXIN : 5 MG |
| Manufacturer | STIEFEL LABORATORIES (IRELAND) LIMITED |
| Strength | 5 MG |
| Dosage form | LIQUID |
| Route of administration | TOPICAL |
| Schedule | Prescription |
| ATC code | D06BB04 PODOPHYLLOTOXIN |
| AHFS class | 84:92.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 30-Apr-2015 |
| Original market date | 1995-12-31 00:00:00 |
How is it stored and handled?
WARTEC® should be stored at controlled room temperature. Store in light-resistant containers and keep container tightly closed when not in use. Contents are flammable. Keep away from fire, flame or heat. Do not leave WARTEC® solution in direct sunlight.
How is it supplied?
Each pack of WARTEC® consists of a bottle containing 3 mL of WARTEC® solution and a tube of double-ended applicators.
What can be used instead?
Other Canadian products sharing ATC code D06BB04 PODOPHYLLOTOXIN. 0 of 3 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| CONDYLINE | 0.5 % | SOLUTION | SANOFI-AVENTIS CANADA INC | CANCELLED POST MARKET | DIN 01945149 |
| PODOFILM LIQ 250MG/ML | 250 MG | LIQUID | PALADIN PHARMA INC. | CANCELLED POST MARKET | DIN 00598208 |
Who else supplies PODOPHYLLOTOXIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. PODOPHYLLOTOXIN appears in 663 registered pack listings across 3 markets, published on 3 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.